Contributors: Pellegrini, C; Botta, F; Massi, D; Martorelli, C; Facchetti, F; Gandini, S; Maisonneuve, P; Avril, Mf; Demenais, F; Bressac-de Paillerets, B; Hoiom, V; Cust, Ae; Anton-Culver, H; Gruber, Sb; Gallagher, Rp; Marrett, L; Zanetti, R; Dwyer, T; Thomas, Ne; Begg, Cb; Berwick, M; Puig, S; Potrony, M; Nagore, E; Ghiorzo, P; Menin, C; Manganoni, Am; Rodolfo, M; Brugnara, S; Passoni, E; Sekulovic, Lk; Baldini, F; Guida, G; Stratigos, A; Ozdemir, F; Ayala, F; Fernandez-de-Misa, R; Quaglino, P; Ribas, G; Romanini, A; Migliano, E; Stanganelli, I; Kanetsky, Pa; Pizzichetta, Ma; García-Borrón, Jc; Nan, H; Landi, Mt; Little, J; Newton-Bishop, J; Sera, F; Fargnoli, Mc; Raimondi, S; IMI Study, Group; GEM Study, Group; M-SKIP Study, Group
نبذة مختصرة : Germline variants in MC1R may increase risk of childhood/adolescent melanoma, but a clear conclusion is challenging because of the limited number of studies and cases. We evaluated the association of MC1R variants and childhood/adolescent melanoma in a large study comparing the prevalence of MC1R variants of childhood/adolescent melanoma patients to that among adult melanoma cases and unaffected controls.
No Comments.